National Cheng Kung University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:National Cheng Kung University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10621
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
National Cheng Kung University (NCKU) is a research-led comprehensive university that offers educational and research services. The university’s services include graduate, undergraduate and postgraduate courses, research programs, master’s programs, degree programs, doctoral courses, doctor’s degree programs and continuing graduate programs. It also provides nursing courses, clinical medicine courses, clinical pharmacy and pharmaceutical sciences courses, cell biology and anatomy courses, internal medicine courses, family medicine courses, food safety, hygiene and risk management programs. NCKU offers general education courses, progressive education courses, cross college elite programs, master academic programs in drama, center for theoretical sciences and AS graduate programs, among others. The university provides its services through its colleges, centers, institutes and departments. NCKU is headquartered in Tainan, Taiwan.

National Cheng Kung University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
National Cheng Kung University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Cheng Kung University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
National Cheng Kung University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Cheng Kung University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
National Cheng Kung University, Medical Devices Deals, 2012 to YTD 2018 9
National Cheng Kung University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
National Cheng Kung University, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
National Cheng Kung University Enters Into Co-Development Agreement With Ohio State University 11
Licensing Agreements 12
Inform Genomics Enters into Licensing Agreement with National Cheng Kung University 12
Novo Nordisk Announces Licensing Agreement With National Cheng Kung University For Anti-IL-20 13
National Cheng Kung University – Key Competitors 14
National Cheng Kung University – Key Employees 15
National Cheng Kung University – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
National Cheng Kung University, Pharmaceuticals & Healthcare, Key Facts 2
National Cheng Kung University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Cheng Kung University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
National Cheng Kung University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Cheng Kung University, Deals By Therapy Area, 2012 to YTD 2018 8
National Cheng Kung University, Medical Devices Deals, 2012 to YTD 2018 9
National Cheng Kung University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
National Cheng Kung University Enters Into Co-Development Agreement With Ohio State University 11
Inform Genomics Enters into Licensing Agreement with National Cheng Kung University 12
Novo Nordisk Announces Licensing Agreement With National Cheng Kung University For Anti-IL-20 13
National Cheng Kung University, Key Competitors 14
National Cheng Kung University, Key Employees 15
National Cheng Kung University, Subsidiaries 16

List of Figures
National Cheng Kung University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
National Cheng Kung University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
National Cheng Kung University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
National Cheng Kung University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
National Cheng Kung University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National Cheng Kung University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
National Cheng Kung University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National Cheng Kung University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
National Cheng Kung University, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[National Cheng Kung University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sysmex Corp (6869):医療機器:M&Aディール及び事業提携情報
    Summary Sysmex Corp (Sysmex) is a supplier of medical devices. It researches, develops, manufactures and sells instruments, reagents, and software applications that facilitate health checkups, treatment and disease management. The company offers diagnostic instruments, reagents and laboratory inform …
  • Black Ridge Oil & Gas Inc (ANFC):石油・ガス:M&Aディール及び事業提携情報
    Summary Black Ridge Oil & Gas Inc (Black Ridge), formerly Ante5 Inc is an oil and gas company that acquires, develops, explores and produces crude oil and natural gas properties. The company's projects are located in Bakken and three Forks trends in Montana and North Dakota. It acquires gas assets t …
  • TYI 2011 Ltd:企業の戦略的SWOT分析
    TYI 2011 Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Solaria Energia y Medio Ambiente S.A. (SLR):企業の財務・戦略的SWOT分析
    Solaria Energia y Medio Ambiente S.A. (SLR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key streng …
  • Westpac Banking Corporation:企業の戦略・SWOT・財務情報
    Westpac Banking Corporation - Strategy, SWOT and Corporate Finance Report Summary Westpac Banking Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Second Sight Medical Products Inc (EYES):企業の財務・戦略的SWOT分析
    Summary Second Sight Medical Products Inc (Second Sight) is a medical device company. It develops, manufactures and markets implantable visual prosthetics for blind individuals. The company offers Argus II retinal prosthesis system, a device that restores some functional vision for people suffering …
  • Alberta Investment Management Corporation:企業の戦略・SWOT・財務情報
    Alberta Investment Management Corporation - Strategy, SWOT and Corporate Finance Report Summary Alberta Investment Management Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • AVX Corporation (AVX):企業の財務・戦略的SWOT分析
    AVX Corporation (AVX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • T2 Biosystems Inc (TTOO):企業の財務・戦略的SWOT分析
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. T2 Biosystems offers T2HemoSta …
  • Idacorp Inc (IDA):企業の財務・戦略的SWOT分析
    Summary Idacorp Inc (Idacorp) is an electric utility that distributes, markets, generates and purchases electricity. The utility owns natural gas-fired power plants and in coal-fired generating stations. It offers real estate investments and housing projects. Idacorp owns three coal-fired generating …
  • OGK-2 (OGKB):企業の財務・戦略的SWOT分析
    OGK-2 (OGKB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pote …
  • Antabio SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Antabio SAS (Antabio) is a biopharmaceutical company that develops novel antibacterials targeting drug-resistant pathogens. The company’s pipeline products comprise Metallo Beta-Lactamases inhibitors, Pseudomonas Biofilms inhibitors and others. It uses in vitro technologies and bacterial dis …
  • Orchids Paper Products Co:企業の戦略的SWOT分析
    Orchids Paper Products Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Illumina, Inc.:企業の戦略・SWOT・財務情報
    Illumina, Inc. - Strategy, SWOT and Corporate Finance Report Summary Illumina, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Canadian Cancer Trials Group:製薬・医療:M&Aディール及び事業提携情報
    Summary Canadian Cancer Trials Group (CCTG), is a subsidiary of Cancer Research Institute at Queen's University, is a contract research organization that conducts clinical trials. The company conducts trials for the development of new drugs and therapies for the treatment of various diseases. It pro …
  • Barra Resources Limited:企業の戦略・SWOT・財務情報
    Barra Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Barra Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Alkem Laboratories Ltd (ALKEM):製薬・医療:M&Aディール及び事業提携情報
    Summary Alkem Laboratories Ltd (Alkem) is a pharmaceutical company that develops, manufactures and markets generic and specialty pharmaceutical products. The company’s products include active pharmaceutical ingredients, generic products, branded products and nutraceuticals. Alkem provides drugs for …
  • Tech Mahindra Limited (TECHM):企業の財務・戦略的SWOT分析
    Tech Mahindra Limited (TECHM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Novanta Inc (NOVT):医療機器:M&Aディール及び事業提携情報
    Summary Novanta Inc (Novanta), formerly GSI Group Inc is a medical device company that manufactures and markets precision photonics, motion control components and subsystems. The company provides laser products, medical technologies, and precision motion products. It offers laser sources and beam de …
  • Eurasian Natural Resources Corporation Ltd:企業のM&A・事業提携・投資動向
    Eurasian Natural Resources Corporation Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eurasian Natural Resources Corporation Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detai …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆